Seeking Alpha

More on Kimberly-Clark's (KMB) Q2: Overall, revenue growth comes in flat. Organic revenues rise...

More on Kimberly-Clark's (KMB) Q2: Overall, revenue growth comes in flat. Organic revenues rise 3% as the international business offsets "mixed volume performance" in developed countries. Adjusted operating profit rises 6% and adjusted operating margin climbs 80 basis points. An interesting tidbit from the segment results which may have wider implications for the market: "Surgical and infection prevention volumes were down low-single digits, primarily due to declines in exam gloves" and medical device volumes posted only a slight gain after logging double-digit growth in Q2 2012. Full year outlook: $5.60-5.75/ share. (PR)
Comments (2)
  • theo_rhetoric
    , contributor
    Comments (166) | Send Message
     
    "-primarily due to declines in exam gloves"
    Come on people - go get those cavity exams.
    22 Jul 2013, 10:01 AM Reply Like
  • tony1066
    , contributor
    Comments (77) | Send Message
     
    Long Kmb
    22 Jul 2013, 11:17 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector